维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Sasso O"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension显示文摘	Carbonara O Persico M Iafusco D Salvatore T D' Ambrosio R	2002	Diabetes Care2002，25，11：	1
2	A catalytically silent FAAH-1 variant drives anandamide transport in neurons 显示文摘	Fu J Bottegoni G Sasso O	2011	Nat Neurosci2011，15，：	1
3	Increased vascular endothelial growth factor mRNA expression in the heart of streptozotocin-induccd diabetic rat显示文摘	Sasso FC Carbonara O and Persico E et aI	2003	Metabolism2003，52，：	1
4	Cardiovascular Risk Factors and Disease Management in Type 2 Diabetic Patients With Diabetic Nephropathy显示文摘	Sasso FC De Nicola L Carbonara O	2006	Diabetes Care2006，29，3：	1
5	Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension:a randomized double-blind placebo-controlled crossover study显示文摘	Sasso FC Carbonara O Persico M	2002	Diabetes Care2002，25，11：	1
6	Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models显示文摘	SASSO O MORENO-SANZ G MARTUCCI C	2013	PAIN?2013，154，3：	1
7	increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor reeeptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 显示文摘	Sasso FC Torella D Carhonara O	2005	J Am Coll Cardiol2005，46，5：	1
8	Unstable thoracolumbar burst fractures: anterior-only versus sbort-segment posterior fixation显示文摘	Sasso RC Renkens K Hanson O	2006	J Spinal Disord Tecb2006，19，4：	1
9	Glucose metabolism and coronary heart disease in patients with normal glucose tolerance显示文摘	Sasso FC Carbonara O Nasti R	2004	JAMA2004，291，15：	1
10	Perspectives of nuclear diagnostic imaging in diabetic cardiomyopathy显示文摘	Sasso FC Rambaldi PF Carbonara O	2010	Nutr Metab Cardiovasc Dis2010，20，3：	1
11	查看详情显示文摘	Sasso C Fenoll M Stephan O Beneventi D		0，，04：	1
12	Car diovascular Risk Factors and Disease Management in Type 2 Diabetic Patients WithDiabetic Nephropathy显示文摘	Sasso FC De Nicola L Carbo nara O	2006	Diabetes Care2006，29，3：	1
13	Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice involvement of atlopreg- nanolone biosynthesis 显示文摘	Sasso O La RG Vitiello S	2010	Eur Neuropsychopharmacol2010，20，3：	1
14	Cardiovascular risk factors and disease management in type 2 diabetic patients with dia- betic nephropathy显示文摘	Sasso F C De Nicola L Carbonara O	2006	Diabetes Care2006，29，3：	1
15	Irbesartan reduces the albumin excretion rate in microalbuminurie type 2 dia- betc patients independently of hypertension 显示文摘	Sasso Fc Carbonara O Persico M	2002	Diabetes Care2002，25，10：	1
16	Glucose Metabolism and Coronaryheart Disease in Patients with Normal Glucose Tolerance显示文摘	Sasso F C Carbonara O Nasti R	2004	JAMA2004，291，15：	1
17	Cardiovascular Risk Factors and Disease Management in Type 2 Diabetic Patients with Diabetic Nephropathy显示文摘	Sasso FC Nicola LD Carbonara O etal	2006	Diabetes Care2006，29，3：	1
18	Irbesartan reduces thealbumin excretion rate in microalbuminuric type 2 diabet- ic patients显示文摘	Sasso FC Carbonara O Persico M	2002	Diabetic Care2002，25，11：	1
19	Glucose metabolism and coronary heart disease in patients with normal glucose tolerance显示文摘	Sasso FC Carbonara O Nasti R	2004	JAMA2004，291，15：	1
20	Increased vas- cular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coro- nary heart disease 显示文摘	Sasso FC Torella D Carbonara O	2005	J Am Coll Cardiol2005，46，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示